Accunome Sciences, a Delaware company, is a new startup company building ultra-sensitive molecular diagnostic tests for infectious respiratory diseases. We very recently closed a USD$4M round of funding from overseas (China) venture capitalists to begin proof-of-concept R&D on our novel molecular detection platform.
Developing analytical devices for the life sciences.
Brightseed discovers plant-based nutritional bioactives and incorporates them into everyday food products. By restoring nutrients that have been lost in our modern diet, Brightseed strengthens the body’s inherent ability to maintain good health.
Our company is committed to developing the next generation of oncolytic viruses for cancer diagnosis and treatment.
CellFE is an early stage life sciences company that brings innovative technology to engineer cell therapies to fight cancer and other challenging diseases.